Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Outpatients~* Sexually active women participating in the study must use a medically acceptable form of contraception~* Subjects must have a primary diagnosis of major depressive disorder~Exclusion Criteria:~* Treatment with DVS-233 SR at any time in the past~* Treatment with venlafaxine (immediate release \[IR\] or extended release \[ER\]) within 90 days of study day 1~* Known hypersensitivity to venlafaxine (IR or ER)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).